2023 Q3 Form 10-K Financial Statement
#000149315223029992 Filed on August 23, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2023 |
---|---|---|---|
Revenue | $796.1K | $440.0K | $1.257M |
YoY Change | 155.72% | 558.09% | 187.52% |
Cost Of Revenue | $563.8K | $390.0K | $930.2K |
YoY Change | |||
Gross Profit | $232.3K | $50.00K | $326.7K |
YoY Change | |||
Gross Profit Margin | 29.18% | 11.36% | 25.99% |
Selling, General & Admin | $2.460M | $2.430M | $8.030M |
YoY Change | 69.66% | 66.17% | 63.21% |
% of Gross Profit | 1058.83% | 4860.0% | 2458.15% |
Research & Development | $100.0K | $130.0K | $510.0K |
YoY Change | 25.0% | -81.23% | -86.77% |
% of Gross Profit | 43.04% | 260.0% | 156.12% |
Depreciation & Amortization | $247.6K | $110.0K | $814.5K |
YoY Change | |||
% of Gross Profit | 106.57% | 220.0% | 249.33% |
Operating Expenses | $2.869M | $2.700M | $13.66M |
YoY Change | 87.53% | 25.29% | 55.68% |
Operating Profit | -$2.526M | -$2.650M | -$12.60M |
YoY Change | 107.36% | 51.08% | |
Interest Expense | $90.00K | $30.00K | $1.930M |
YoY Change | -33433.33% | 66451.72% | |
% of Operating Profit | |||
Other Income/Expense, Net | $93.94K | $1.931M | |
YoY Change | 2087.73% | 66475.1% | |
Pretax Income | -$2.430M | -$2.670M | -$10.66M |
YoY Change | 100.83% | 27.86% | 27.91% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$2.425M | -$2.660M | -$10.63M |
YoY Change | 100.71% | 28.0% | 28.0% |
Net Earnings / Revenue | -304.64% | -604.55% | -845.89% |
Basic Earnings Per Share | -$1.04 | -$10.58 | |
Diluted Earnings Per Share | -$1.04 | -$2.11 | -$10.58 |
COMMON SHARES | |||
Basic Shares Outstanding | 2.330M shares | 1.733M shares | 1.005M shares |
Diluted Shares Outstanding | 2.330M shares | 1.005M shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $190.0K | $1.540M | $1.540M |
YoY Change | -96.69% | -81.31% | -81.31% |
Cash & Equivalents | $186.4K | $1.537M | |
Short-Term Investments | |||
Other Short-Term Assets | $413.3K | $552.8K | $510.0K |
YoY Change | 177.52% | -25.97% | 212.63% |
Inventory | $965.1K | $979.9K | $980.0K |
Prepaid Expenses | $360.0K | ||
Receivables | $567.5K | $293.9K | $290.0K |
Other Receivables | $560.0K | $20.13K | $540.0K |
Total Short-Term Assets | $2.692M | $3.863M | $3.860M |
YoY Change | -67.2% | -64.46% | -64.48% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $664.9K | $690.2K | $1.240M |
YoY Change | 59.83% | 76.33% | 216.8% |
Goodwill | $3.803M | ||
YoY Change | |||
Intangibles | $4.872M | $5.255M | |
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $6.009M | $6.492M | $6.490M |
YoY Change | 207.76% | 337.42% | 337.28% |
TOTAL ASSETS | |||
Total Short-Term Assets | $2.692M | $3.863M | $3.860M |
Total Long-Term Assets | $6.009M | $6.492M | $6.490M |
Total Assets | $8.700M | $10.35M | $10.35M |
YoY Change | -14.36% | -16.17% | -16.21% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.630M | $1.200M | $1.200M |
YoY Change | 855.26% | 67.62% | 67.62% |
Accrued Expenses | $630.0K | $777.1K | $1.360M |
YoY Change | -34.38% | -30.03% | 22.47% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $340.0K | $350.0K | $350.0K |
YoY Change | |||
Total Short-Term Liabilities | $6.846M | $5.884M | $5.880M |
YoY Change | 190.43% | 26.18% | 26.1% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $310.0K | $400.0K | $400.0K |
YoY Change | |||
Other Long-Term Liabilities | $310.0K | $380.0K | $380.0K |
YoY Change | -88.12% | -66.77% | -66.77% |
Total Long-Term Liabilities | $620.0K | $780.0K | $780.0K |
YoY Change | -76.25% | -31.78% | -31.78% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.846M | $5.884M | $5.880M |
Total Long-Term Liabilities | $620.0K | $780.0K | $780.0K |
Total Liabilities | $7.464M | $6.668M | $6.560M |
YoY Change | 50.37% | 14.83% | 14.54% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$44.23M | -$41.81M | |
YoY Change | 36.59% | 34.1% | |
Common Stock | $23.30K | $23.30K | |
YoY Change | -84.35% | -84.35% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $14.00 | $14.00 | |
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.356M | $3.799M | $3.800M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.700M | $10.35M | $10.35M |
YoY Change | -14.36% | -16.17% | -16.21% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.425M | -$2.660M | -$10.63M |
YoY Change | 100.71% | 28.0% | 28.0% |
Depreciation, Depletion And Amortization | $247.6K | $110.0K | $814.5K |
YoY Change | |||
Cash From Operating Activities | -$1.312M | -$590.0K | -$7.377M |
YoY Change | -30.73% | -65.76% | 119.69% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | $363.5K | ||
YoY Change | |||
Other Investing Activities | $0.00 | -$180.0K | -$690.0K |
YoY Change | -100.0% | -74.4% | -21.61% |
Cash From Investing Activities | -$180.0K | -$694.1K | |
YoY Change | -74.4% | -21.14% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 50.00K | $1.435M | |
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -$1.312M | -590.0K | -$7.377M |
Cash From Investing Activities | -180.0K | -$694.1K | |
Cash From Financing Activities | 50.00K | $1.435M | |
Net Change In Cash | -$1.351M | -720.0K | -$6.701M |
YoY Change | -45.87% | -70.32% | 54.57% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.312M | -$590.0K | -$7.377M |
Capital Expenditures | |||
Free Cash Flow | -$7.377M | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001725430 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
2256 | |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
usd | |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
usd | |
CY2023Q2 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
usd | |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
usd | |
CY2022Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
usd | |
CY2023Q2 | us-gaap |
Grants Receivable Noncurrent
GrantsReceivableNoncurrent
|
usd | |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
usd | |
CY2022Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
usd | |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
usd | |
CY2023Q2 | us-gaap |
Deferred Income Noncurrent
DeferredIncomeNoncurrent
|
usd | |
CY2022Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
usd | |
CY2023Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
usd | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
usd | |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
usd | |
CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
usd | |
CY2022 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
usd | |
CY2022 | INBS |
Stock Issued During Period Value Series B Warrants Exercised To Purchase Common Shares
StockIssuedDuringPeriodValueSeriesBWarrantsExercisedToPurchaseCommonShares
|
usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
CY2023 | INBS |
Stock Issued During Period Reverse Stock Split Rounding Adjustment
StockIssuedDuringPeriodReverseStockSplitRoundingAdjustment
|
usd | |
CY2023 | INBS |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
usd | |
CY2022 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
usd | |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
usd | |
CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
usd | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | |
CY2023 | INBS |
Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
|
usd | |
CY2022 | INBS |
Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
|
usd | |
CY2022 | INBS |
Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
|
usd | |
CY2022 | INBS |
Cash Acquired From Business Acquisition
CashAcquiredFromBusinessAcquisition
|
usd | |
CY2022 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
usd | |
CY2022 | INBS |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
usd | |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
usd | |
CY2022 | INBS |
Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
|
usd | |
CY2022 | INBS |
Payment Of Tax Withholding For Employee Stock Awards
PaymentOfTaxWithholdingForEmployeeStockAwards
|
usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2022 | INBS |
Shares Issued For Business Acquisition
SharesIssuedForBusinessAcquisition
|
usd | |
CY2022 | INBS |
Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
|
usd | |
CY2022 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
usd | |
CY2022 | INBS |
Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
|
usd | |
CY2022 | INBS |
Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
|
usd | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
usd | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
usd | |
CY2022 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
usd | |
CY2022Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
usd | |
CY2022Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
usd | |
CY2022Q2 | INBS |
Less Provision For Inventory Obsolescence
LessProvisionForInventoryObsolescence
|
usd | |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
usd | |
CY2023Q2 | INBS |
Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
|
usd | |
CY2022Q2 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
usd | |
CY2022Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
usd | |
CY2022Q2 | INBS |
Deferred Consideration Current
DeferredConsiderationCurrent
|
usd | |
CY2022Q2 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
usd | |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
usd | |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
usd | |
CY2023 | us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
usd | |
CY2022Q2 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
usd | |
CY2022Q2 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
usd | |
CY2023Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2022Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | INBS |
Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
|
usd | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-39825 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
Intelligent Bio Solutions Inc. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-1512711 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Intelligent Bio Solutions Inc. | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
142 West, 57th Street | |
CY2023 | dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
11th Floor | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10019 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
646 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
828-8258 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.01 per share | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
INBS | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q4 | dei |
Entity Public Float
EntityPublicFloat
|
3665058 | usd |
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2330399 | shares |
CY2023 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
4200000 | usd |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
1195 | |
CY2023 | dei |
Auditor Name
AuditorName
|
UHY LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Melville, New York | |
CY2022 | dei |
Auditor Name
AuditorName
|
BDO Audit Pty Ltd | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Sydney, Australia | |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1537244 | usd |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8238301 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
293861 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
979907 | usd |
CY2022Q2 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
1529882 | usd |
CY2023Q2 | INBS |
Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
|
498758 | usd |
CY2022Q2 | INBS |
Research And Development Tax Incentive Receivable Current
ResearchAndDevelopmentTaxIncentiveReceivableCurrent
|
353048 | usd |
CY2023Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
552791 | usd |
CY2022Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
746761 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
3862561 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
10867992 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
690175 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
391408 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
546475 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
5255401 | usd |
CY2022Q2 | us-gaap |
Grants Receivable Noncurrent
GrantsReceivableNoncurrent
|
1092773 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
10354612 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
12352173 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2610028 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1625089 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
223447 | usd |
CY2023Q2 | us-gaap |
Deferred Income Current
DeferredIncomeCurrent
|
2338057 | usd |
CY2022Q2 | us-gaap |
Deferred Income Current
DeferredIncomeCurrent
|
2836582 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
358942 | usd |
CY2022Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
201332 | usd |
CY2023Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
353211 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5883685 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4663003 | usd |
CY2023Q2 | INBS |
Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
|
24902 | usd |
CY2022Q2 | INBS |
Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
|
50626 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
356165 | usd |
CY2022Q2 | us-gaap |
Deferred Income Noncurrent
DeferredIncomeNoncurrent
|
1092773 | usd |
CY2023Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
402862 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
6667614 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
5806402 | usd |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2330399 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
744495 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
23304 | usd |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
7445 | usd |
CY2023Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
1386 | shares |
CY2022Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
0 | shares |
CY2023Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
14 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
46158763 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
38581465 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41807573 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-31175853 | usd |
CY2023Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-575496 | usd |
CY2022Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-788135 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3798984 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6624922 | usd |
CY2023Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-111986 | usd |
CY2022Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-79151 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6545771 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10354612 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12352173 | usd |
CY2023 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 20 | |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1256872 | usd |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
930204 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
326668 | usd |
CY2023 | INBS |
Government Support Income
GovernmentSupportIncome
|
737628 | usd |
CY2022 | INBS |
Government Support Income
GovernmentSupportIncome
|
437146 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8026703 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4920103 | usd |
CY2023 | INBS |
Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
|
507424 | usd |
CY2022 | INBS |
Development And Regulatory Approval Expenses
DevelopmentAndRegulatoryApprovalExpenses
|
3853919 | usd |
CY2023 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
966732 | usd |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4158670 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
13659529 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
8774022 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12595233 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8336876 | usd |
CY2023 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
223534 | usd |
CY2022 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
7539 | usd |
CY2023 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-9829 | usd |
CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-3987 | usd |
CY2023 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
2154365 | usd |
CY2023 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
9676 | usd |
CY2022 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
14426 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1930678 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2900 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-10664555 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-8333976 | usd |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-32835 | usd |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-27925 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10631720 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8306051 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
212639 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-126875 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
212639 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-126875 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-10451916 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-8460851 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-32835 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-27925 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10419081 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8432926 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1004593 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1004593 | shares |
CY2023 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 20 | |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
15006622 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-126875 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-8333976 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6545771 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6545771 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
4724270 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
162460 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
260000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
|
14407 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
2093667 | usd |
CY2023 | INBS |
Stock Issued During Period Value Conversion Of Convertible Notes Payable Into Series C Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesPayableIntoSeriesCPreferredStock
|
367153 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
212639 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-10664555 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2023 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 20 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-10664555 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-8333976 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
814481 | usd |
CY2023 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
152251 | usd |
CY2023 | INBS |
Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
|
-9829 | usd |
CY2022 | INBS |
Noncash Gain Loss On Foreign Currency Translation Net
NoncashGainLossOnForeignCurrencyTranslationNet
|
3987 | usd |
CY2023 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
189670 | usd |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4158670 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
260000 | usd |
CY2022 | INBS |
Noncash Research And Development Charge
NoncashResearchAndDevelopmentCharge
|
2600000 | usd |
CY2023 | INBS |
Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
|
127944 | usd |
CY2022 | INBS |
Non Cash Refund Of Rd Expenditure Claims
NonCashRefundOfRdExpenditureClaims
|
50958 | usd |
CY2023 | INBS |
Fair Value Gain On Revaluation Of Convertible Notes
FairValueGainOnRevaluationOfConvertibleNotes
|
-1537565 | usd |
CY2023 | INBS |
Fair Value Gain On Revaluation Of Holdback Series Preferred Stock
FairValueGainOnRevaluationOfHoldbackSeriesPreferredStock
|
-616800 | usd |
CY2023 | INBS |
Noncash Other Operating Activities
NoncashOtherOperatingActivities
|
94332 | usd |
CY2022 | INBS |
Noncash Other Operating Activities
NoncashOtherOperatingActivities
|
8179 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
293861 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
345390 | usd |
CY2023 | INBS |
Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
|
-1031357 | usd |
CY2022 | INBS |
Increase Decrease In Grant Receivable And Deferred Grant Income
IncreaseDecreaseInGrantReceivableAndDeferredGrantIncome
|
-1828891 | usd |
CY2023 | INBS |
Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
|
145710 | usd |
CY2022 | INBS |
Increase Decrease In Research And Development Tax Incentive Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxIncentiveReceivable
|
-672407 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
118335 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
333743 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
84502 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
255978 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
-13323 | usd |
CY2023 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-107922 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-25724 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
28856 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7377378 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3358034 | usd |
CY2022 | us-gaap |
Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
|
500000 | usd |
CY2023 | INBS |
Cash Acquired From Business Acquisition
CashAcquiredFromBusinessAcquisition
|
174481 | usd |
CY2023 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
363500 | usd |
CY2023 | INBS |
Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
|
505123 | usd |
CY2022 | INBS |
Amount Invested On Capital Work In Progress
AmountInvestedOnCapitalWorkInProgress
|
380221 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-694142 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-880221 | usd |
CY2023 | INBS |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
2554463 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
220578 | usd |
CY2023 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
518914 | usd |
CY2023 | INBS |
Payment Of Equity Issuance Costs Relating To Acquisition
PaymentOfEquityIssuanceCostsRelatingToAcquisition
|
806397 | usd |
CY2023 | INBS |
Payment Of Tax Withholding For Employee Stock Awards
PaymentOfTaxWithholdingForEmployeeStockAwards
|
14407 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1435323 | usd |
CY2023 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-64860 | usd |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-97129 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6701057 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4335384 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8238301 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
12573685 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1537244 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8238301 | usd |
CY2023 | INBS |
Shares Issued For Business Acquisition
SharesIssuedForBusinessAcquisition
|
5530667 | usd |
CY2023 | INBS |
Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
|
504938 | usd |
CY2023 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
208500 | usd |
CY2023 | INBS |
Recording Of Rightofuse Asset And Lease Liability
RecordingOfRightofuseAssetAndLeaseLiability
|
702566 | usd |
CY2023 | INBS |
Conversion Of Convertible Notes Payable Into Preferred Stock
ConversionOfConvertibleNotesPayableIntoPreferredStock
|
367153 | usd |
CY2023 | INBS |
Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
|
36888 | usd |
CY2022 | INBS |
Conversion Of Preferred Shares Into Common Shares
ConversionOfPreferredSharesIntoCommonShares
|
13000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-20 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10631720 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8306051 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3686998 | usd |
CY2023Q2 | INBS |
Working Capital Deficit
WorkingCapitalDeficit
|
2021124 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41807573 | usd |
CY2023Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
1537244 | usd |
CY2021Q2 | us-gaap |
Deferred Income
DeferredIncome
|
4700000 | usd |
CY2023Q2 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
646116 | usd |
CY2022Q2 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
391408 | usd |
CY2021Q2 | us-gaap |
Deferred Income
DeferredIncome
|
4700000 | usd |
CY2023 | us-gaap |
Accounts Receivable Sale
AccountsReceivableSale
|
1400000 | usd |
CY2022 | us-gaap |
Accounts Receivable Sale
AccountsReceivableSale
|
2100000 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_849_eus-gaap--UseOfEstimates_zFgXr0WbsAT" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zrgqADXbx8y7">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> | |
CY2023 | INBS |
Earnings Per Share Basic Decreased
EarningsPerShareBasicDecreased
|
0.07 | |
CY2023 | INBS |
Earnings Per Share Diluted Decreased
EarningsPerShareDilutedDecreased
|
10.58 | |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1256872 | usd |
CY2023 | INBS |
Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
|
609684 | usd |
CY2022 | INBS |
Research And Development Tax Refund
ResearchAndDevelopmentTaxRefund
|
385888 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
212639 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
126875 | usd |
CY2023Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
1114687 | usd |
CY2022Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
7816077 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1256872 | usd |
CY2023 | INBS |
Government Support Income
GovernmentSupportIncome
|
737628 | usd |
CY2022 | INBS |
Government Support Income
GovernmentSupportIncome
|
437146 | usd |
CY2023Q2 | INBS |
Property Plant And Equipment Net And Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAsset
|
1236650 | usd |
CY2022Q2 | INBS |
Property Plant And Equipment Net And Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAsset
|
391408 | usd |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zgR8piUpgQtl" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_ziRKCSWtGS4l">Concentration of credit risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places its cash and cash equivalents, which may at times be in excess of the Australia Financial Claims Scheme or the United States’ Federal Deposit Insurance Corporation insurance limits, with high credit quality financial institutions and attempts to limit the amount of credit exposure with any one institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> | |
CY2022Q4 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
363500 | usd |
CY2022Q4 | INBS |
Note Receivable Settled For Business Acquisition
NoteReceivableSettledForBusinessAcquisition
|
504938 | usd |
CY2022Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
|
7224404 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
174481 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
|
774625 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
|
345038 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
|
52170 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
|
5463000 | usd |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
3803293 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
|
10612607 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
|
1027302 | usd |
CY2023Q2 | INBS |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayable
|
-677137 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
|
1683764 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
|
3388203 | usd |
CY2023Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
|
7224404 | usd |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4158670 | usd |
CY2023 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
1256872 | usd |
CY2023 | us-gaap |
Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
|
-10664555 | usd |
CY2022 | us-gaap |
Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
|
-8333976 | usd |
CY2023 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-10631720 | usd |
CY2022 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-8306051 | usd |
CY2023 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-10.58 | |
CY2022 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-11.33 | |
CY2023Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
419889 | usd |
CY2023Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
757518 | usd |
CY2023Q2 | INBS |
Less Provision For Inventory Obsolescence
LessProvisionForInventoryObsolescence
|
197500 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
979907 | usd |
CY2022Q2 | INBS |
Intelligent Fingerprinting Limited Note Receivable
IntelligentFingerprintingLimitedNoteReceivable
|
500445 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
359953 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
116525 | usd |
CY2023Q2 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
20418 | usd |
CY2022Q2 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
57746 | usd |
CY2023Q2 | us-gaap |
Deposit Assets
DepositAssets
|
118193 | usd |
CY2022Q2 | us-gaap |
Deposit Assets
DepositAssets
|
46602 | usd |
CY2023Q2 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
34100 | usd |
CY2023Q2 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
20127 | usd |
CY2022Q2 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
25443 | usd |
CY2023Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
552791 | usd |
CY2022Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
746761 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
723944 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
391408 | usd |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
33769 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
690175 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
391408 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
33769 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
0 | usd |
CY2023Q2 | INBS |
Percentage Of Reimbursement On Construction Cost
PercentageOfReimbursementOnConstructionCost
|
0.50 | pure |
CY2023Q2 | INBS |
Investments In Construction In Progress
InvestmentsInConstructionInProgress
|
1292232 | usd |
CY2022Q2 | INBS |
Investments In Construction In Progress
InvestmentsInConstructionInProgress
|
782816 | usd |
CY2023Q2 | INBS |
Government Grant
GovernmentGrant
|
646116 | usd |
CY2022Q2 | INBS |
Government Grant
GovernmentGrant
|
391408 | usd |
CY2023Q2 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
646116 | usd |
CY2022Q2 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
391408 | usd |
CY2023Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
1196222 | usd |
CY2022Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
715902 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
777086 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
909187 | usd |
CY2023Q2 | INBS |
Deferred Consideration Current
DeferredConsiderationCurrent
|
208500 | usd |
CY2023Q2 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
428220 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2610028 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1625089 | usd |
CY2023 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
4200000 | usd |
CY2023 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
3803293 | usd |
CY2023 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
355377 | usd |
CY2023 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
-4158670 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
5463000 | usd |
CY2023Q2 | INBS |
Effect Of Foreign Currency On Goodwill
EffectOfForeignCurrencyOnGoodwill
|
643183 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
850782 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
5255401 | usd |
CY2023 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
850782 | usd |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
0 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
884416 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
884416 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
814135 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
790708 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
790708 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
988384 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
5152767 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0097 | pure |
CY2023 | INBS |
Percentage Of Gross Revenue Received
PercentageOfGrossRevenueReceived
|
0.10 | pure |
CY2023 | INBS |
Percentage Of Subsequent Sales To Distributor
PercentageOfSubsequentSalesToDistributor
|
0.50 | pure |
CY2023 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
152251 | usd |
CY2023 | INBS |
Interest On Operating Lease Liabilities
InterestOnOperatingLeaseLiabilities
|
68357 | usd |
CY2023 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
220608 | usd |
CY2023Q2 | us-gaap |
Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
|
P2Y3M18D | |
CY2023Q2 | us-gaap |
Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
|
0.132 | pure |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
295369 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
308749 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
83534 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
687652 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
108040 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
579612 | usd |
CY2023Q2 | INBS |
Offering Expenses
OfferingExpenses
|
2550000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
25000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
260000 | usd |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
260000 | usd | |
CY2023 | us-gaap |
Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
|
1386 | shares |
CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
5347487 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
1682879 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
153199 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
59546 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
38034 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
77539 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9530704 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6064025 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9530704 | usd |
CY2023Q2 | us-gaap |
Purchase Obligation
PurchaseObligation
|
0 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
3914445 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
4321600 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6064025 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-2310635 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1770915 | usd |
CY2023 | INBS |
Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
|
-18715 | usd |
CY2022 | INBS |
Income Tax Reconciliation Income Tax Expense Benefit At Different Tax Rate Of Subsidiary
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtDifferentTaxRateOfSubsidiary
|
-106634 | usd |
CY2023 | INBS |
Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
|
680221 | usd |
CY2022 | INBS |
Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
|
117039 | usd |
CY2023 | INBS |
Income Tax Reconciliation Tax Benefit On Carry Forward Losses Of Acquired Business
IncomeTaxReconciliationTaxBenefitOnCarryForwardLossesOfAcquiredBusiness
|
-3289886 | usd |
CY2023 | INBS |
Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
|
1681562 | usd |
CY2022 | INBS |
Income Tax Reconciliation Cumulative Adjustment To Deferred Taxes
IncomeTaxReconciliationCumulativeAdjustmentToDeferredTaxes
|
1643216 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
-209226 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3466679 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-117294 | usd |
CY2023Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
44492527 | usd |
CY2022Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
27310563 | usd |